DNA Oxidative Damage Kit - Quantitative
DNA Oxidative Damage Kit - Quantitative
DN-002
Kamiya Biomedical Company 20 tests
Fas Ligand Protein, soluble
Fas Ligand Protein, soluble
FL-101
Kamiya Biomedical Company 10 µg
Fas Ligand, Soluble Human (no enhancer required)
Fas Ligand, Soluble Human (no enhancer required)
FL-103
Kamiya Biomedical Company 5 ug
sFas Ligand Enhancer
sFas Ligand Enhancer
FL-104
Kamiya Biomedical Company 1 x 50 ug
Caspase Inhibitor Negative Control (Cathepsin B Inhibitor) (Z-FA-FMK)
Caspase Inhibitor Negative Control (Cathepsin B Inhibitor) (Z-FA-FMK)
AE-001
Kamiya Biomedical Company 5 mg
LPO-CC Kit
LPO-CC Kit
CC-004
Kamiya Biomedical Company 165 mL
Fas Ligand [CD95 Ligand] Inhibitor
Fas Ligand [CD95 Ligand] Inhibitor
AF-016
Kamiya Biomedical Company 50 µg
Caspase-1 / ICE Fluorogenic Substrate 2 (Ac-YVAD-AFC)
Caspase-1 / ICE Fluorogenic Substrate 2 (Ac-YVAD-AFC)
AC-001
Kamiya Biomedical Company 10 mg
Caspase-3 / CPP32 Fluorogenic Substrate (Ac-DEVD-AFC)
Caspase-3 / CPP32 Fluorogenic Substrate (Ac-DEVD-AFC)
AC-003
Kamiya Biomedical Company 10 mg
Caspase-8 / FLICE Fluorogenic Substrate (Ac-IETD-AFC)
Caspase-8 / FLICE Fluorogenic Substrate (Ac-IETD-AFC)
AC-004
Kamiya Biomedical Company 5 mg
Caspase-6 Fluorogenic Substrate (Ac-VEID-AFC)
Caspase-6 Fluorogenic Substrate (Ac-VEID-AFC)
AC-007
Kamiya Biomedical Company 10 mg
Caspase-2, 3 Fluorogenic Substrate (Ac-VDVAD-AFC)
Caspase-2, 3 Fluorogenic Substrate (Ac-VDVAD-AFC)
AC-008
Kamiya Biomedical Company 5 mg
Caspase-4,5,9 Fluorogenic Substrate (Ac-LEHD-AFC)
Caspase-4,5,9 Fluorogenic Substrate (Ac-LEHD-AFC)
AC-010
Kamiya Biomedical Company 5 mg
Caspase-3/CPP32 Substrate-pNA (Ac-DEVD-pNA)
Caspase-3/CPP32 Substrate-pNA (Ac-DEVD-pNA)
AC-024
Kamiya Biomedical Company 25 mg
Caspase-8 Substrate-pNA (Ac-IETD-pNA)
Caspase-8 Substrate-pNA (Ac-IETD-pNA)
AC-025
Kamiya Biomedical Company 25 mg
Caspase-6 Substrate-pNA (Ac-VEID-pNA)
Caspase-6 Substrate-pNA (Ac-VEID-pNA)
AC-026
Kamiya Biomedical Company 25 mg
Caspase-2,3 Substrate -pNA (Ac-VDVAD-pNA)
Caspase-2,3 Substrate -pNA (Ac-VDVAD-pNA)
AC-027
Kamiya Biomedical Company 25 mg
Caspase-4,5,9 Substrate -pNA (Ac-LEHD-pNA)
Caspase-4,5,9 Substrate -pNA (Ac-LEHD-pNA)
AC-028
Kamiya Biomedical Company 25 mg
Caspase-1,4,5 Substrate -pNA (Ac-WEHD-pNA)
Caspase-1,4,5 Substrate -pNA (Ac-WEHD-pNA)
AC-029
Kamiya Biomedical Company 25 mg
Granzyme B Substrate 2-pNA (Ac-IEPD-pNA)
Granzyme B Substrate 2-pNA (Ac-IEPD-pNA)
AC-030
Kamiya Biomedical Company 25 mg
Caspase-3 / CPP32 Inhibitor / Biotin Tag (Biotin-DEVD-FMK)
Caspase-3 / CPP32 Inhibitor / Biotin Tag (Biotin-DEVD-FMK)
AD-003
Kamiya Biomedical Company 1 mg
Caspase Inhibitor Negative Control / Biotin Tag (Cathepsin B Inhibitor / Biotin Tag) (Biotin-FA-FMK)
Caspase Inhibitor Negative Control / Biotin Tag (Cathepsin B Inhibitor / Biotin Tag) (Biotin-FA-FMK)
AD-012
Kamiya Biomedical Company 5 mg
EDG-1 Blocking Peptide
EDG-1 Blocking Peptide
BC-008
Kamiya Biomedical Company 50 ug
EDG-1 Control
EDG-1 Control
BC-009
Kamiya Biomedical Company 100 uL
EDG-2 Blocking Peptide
EDG-2 Blocking Peptide
BC-010
Kamiya Biomedical Company 50 ug
EDG-2 Control
EDG-2 Control
BC-011
Kamiya Biomedical Company 100 uL
EDG-4 Control
EDG-4 Control
BC-012
Kamiya Biomedical Company 100 uL
EDG-6 Blocking Peptide
EDG-6 Blocking Peptide
BC-013
Kamiya Biomedical Company 50 ug
EDG-6 Control
EDG-6 Control
BC-014
Kamiya Biomedical Company 100 uL
EDG-7 Blocking Peptide
EDG-7 Blocking Peptide
BC-015
Kamiya Biomedical Company 50 ug
EDG-7 Control
EDG-7 Control
BC-016
Kamiya Biomedical Company 100 uL
EDG-8 Blocking Peptide
EDG-8 Blocking Peptide
BC-017
Kamiya Biomedical Company 50 ug
JC-1, Iodide
JC-1, Iodide
BC-031
Kamiya Biomedical Company 5 mg
PARP-1, human recombinant
PARP-1, human recombinant
BC-032
Kamiya Biomedical Company 20 ug
PARP-2, mouse recombinant
PARP-2, mouse recombinant
BC-033
Kamiya Biomedical Company 20 ug
DAF-2 DA
DAF-2 DA
BC-034
Kamiya Biomedical Company 1 mg
DAR-4M AM (Cell Permeable)
DAR-4M AM (Cell Permeable)
BC-039
Kamiya Biomedical Company 1 mg
[Boc-Asp(Obzl)-Lys(z)-OtBu], Reversin 121
[Boc-Asp(Obzl)-Lys(z)-OtBu], Reversin 121
BC-052
Kamiya Biomedical Company 5 mg
TWEAK
TWEAK
BC-082
Kamiya Biomedical Company 10 ug
Sophoricoside, IL-5 Inhibitor
Sophoricoside, IL-5 Inhibitor
BC-088
Kamiya Biomedical Company 10 mg
PGP-4008, P-GP Inhibitor
PGP-4008, P-GP Inhibitor
BC-090
Kamiya Biomedical Company 2 mg
TRAIL-His tag, soluble (human recombinant)
TRAIL-His tag, soluble (human recombinant)
BC-091
Kamiya Biomedical Company 20 ug
C75
C75
BC-113
Kamiya Biomedical Company 5 mg
Caspase-1, human recombinant, active
Caspase-1, human recombinant, active
BC-116
Kamiya Biomedical Company 25 U
Caspase-1, human recombinant, active
Caspase-1, human recombinant, active
BC-117
Kamiya Biomedical Company 100 U
Caspase-2, human recombinant, active
Caspase-2, human recombinant, active
BC-118
Kamiya Biomedical Company 25 U
Caspase-2, human recombinant, active
Caspase-2, human recombinant, active
BC-119
Kamiya Biomedical Company 100 U
Caspase-4, human recombinant, active
Caspase-4, human recombinant, active
BC-120
Kamiya Biomedical Company 25 U
Caspase-4, human recombinant active
Caspase-4, human recombinant active
BC-121
Kamiya Biomedical Company 100 U
Caspase-9, human recombinant, active
Caspase-9, human recombinant, active
BC-124
Kamiya Biomedical Company 25 U